News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
7,204 Results
Type
Article (58)
Press Release (7146)
Section
Business (2605)
Career Advice (5)
Deals (383)
Drug Development (1318)
FDA (227)
Job Trends (412)
News (4256)
Policy (225)
Tag
Academia (8)
Accelerated approval (1)
Allergies (6)
Alliances (90)
ALS (6)
Alzheimer's disease (61)
Antibody-drug conjugate (ADC) (12)
Approvals (282)
Artificial intelligence (6)
Autoimmune disease (6)
Automation (1)
Best Places to Work (463)
Biosimilars (2)
Bladder cancer (14)
Breast cancer (37)
Cancer (250)
Cardiovascular disease (27)
Career advice (4)
CAR-T (3)
Cell therapy (11)
Cervical cancer (4)
Clinical research (1476)
Collaboration (18)
Compensation (5)
COVID-19 (11)
CRISPR (4)
C-suite (3)
Data (372)
Depression (3)
Dermatology (2)
Diabetes (13)
Diagnostics (75)
Drug discovery (3)
Drug pricing (1)
Duchenne muscular dystrophy (4)
Earnings (3044)
Events (770)
Executive appointments (1)
FDA (398)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (1)
Funding (11)
Gene editing (5)
Generative AI (1)
Gene therapy (14)
GLP-1 (16)
Government (25)
Guidances (57)
Healthcare (168)
HIV (4)
Huntington's disease (1)
IgA nephropathy (6)
Immunology and inflammation (2)
Indications (8)
Infectious disease (21)
Inflammatory bowel disease (4)
Influenza (2)
Intellectual property (2)
IPO (326)
IRA (1)
Job creations (6)
Job search strategy (4)
Kidney cancer (2)
Layoffs (3)
Legal (11)
Liver cancer (1)
Lung cancer (57)
Lymphoma (28)
Machine learning (1)
Manufacturing (5)
MASH (8)
Medical device (207)
Medtech (209)
Mergers & acquisitions (76)
Metabolic disorders (26)
mRNA (1)
Multiple sclerosis (10)
NASH (2)
Neurodegenerative disease (7)
Neuroscience (107)
NextGen: Class of 2026 (17)
Non-profit (20)
Obesity (5)
Opinion (1)
Ovarian cancer (11)
Pain (2)
Pancreatic cancer (5)
Parkinson's disease (15)
Partnered (1)
Patents (3)
Patient recruitment (3)
Peanut (5)
People (39)
Phase 1 (221)
Phase 2 (443)
Phase 3 (864)
Pipeline (398)
Policy (1)
Postmarket research (86)
Preclinical (34)
Prostate cancer (9)
Radiopharmaceuticals (7)
Rare diseases (20)
Real estate (2)
Regulatory (330)
Reports (2)
Research institute (11)
Resumes & cover letters (2)
Rett syndrome (2)
RSV (6)
Schizophrenia (7)
Series B (2)
Sickle cell disease (2)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (4)
Vaccines (16)
Weight loss (2)
Women's health (3)
Date
Last 7 days (15)
Last 30 days (73)
Last 365 days (893)
2026 (213)
2025 (914)
2024 (777)
2023 (760)
2022 (807)
2021 (873)
2020 (610)
2019 (414)
2018 (359)
2017 (269)
2016 (133)
2015 (188)
2014 (114)
2013 (69)
2012 (93)
2011 (99)
2010 (92)
Location
Africa (2)
Arizona (9)
Asia (542)
Australia (28)
California (306)
Canada (56)
China (35)
Colorado (6)
Connecticut (13)
Delaware (40)
Europe (1307)
Florida (42)
Georgia (8)
Illinois (27)
India (2)
Indiana (29)
Iowa (1)
Japan (38)
Kansas (6)
Louisiana (1)
Maryland (41)
Massachusetts (194)
Michigan (8)
Minnesota (15)
Missouri (3)
Nevada (2)
New Jersey (197)
New York (76)
North Carolina (36)
Northern California (188)
Ohio (9)
Pennsylvania (67)
South America (7)
Southern California (99)
Tennessee (2)
Texas (43)
United States (1199)
Utah (9)
Virginia (4)
Washington State (23)
Wisconsin (2)
7,204 Results for "%E2%80%9D".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Priavoid Presents Initial Phase 2 Data Suggesting Favorable Safety Profile for Alzheimer’s Candidate PRI-002 at AD/PD™ 2026
March 17, 2026
·
4 min read
Press Releases
Alaunos Therapeutics Announces Positive Preclinical Proof-of-Concept Data for ALN1003, a Differentiated Non-Hormonal Oral Treatment for Obesity and Related Metabolic Disorders
March 2, 2026
·
12 min read
Press Releases
FNIH Biomarkers Consortium Study Shows “Clock Model” Blood Test Can Predict Onset of Alzheimer’s Symptoms Years in Advance
February 19, 2026
·
4 min read
Press Releases
Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care
March 30, 2026
·
16 min read
Press Releases
Lebrikizumab delivered long-term disease control for up to four years in patients with moderate-to-severe atopic dermatitis
March 30, 2026
·
9 min read
Press Releases
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance
February 26, 2026
·
25 min read
Press Releases
Athletes with “Never Quit” Mentality Face Increased Risk of ACL Re‑Injury
February 12, 2026
·
6 min read
Press Releases
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2025 Financial Results
February 25, 2026
·
15 min read
Press Releases
WuXi AppTec Beat Full-Year Guidance and Achieved Record Performance in 2025
March 23, 2026
·
19 min read
Press Releases
Merck’s Enlicitide Decanoate, an Investigational Oral PCSK9 Inhibitor, Demonstrated Significantly Greater LDL-C Reductions at Eight Weeks Compared to Guideline-Recommended Oral Non-Statin Therapies When Added to Background Statins
March 30, 2026
·
11 min read
1 of 721
Next
